dichlororibofuranosylbenzimidazole has been researched along with calcitriol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylink, DJ; Kyeyune-Nyombi, E; Lau, KH; Strong, DD | 1 |
| Biskobing, D; Catherwood, BD; Nanes, MS; Rubin, J; Thornton, DL; Titus, L | 1 |
| Liao, JK; Norman, AW; Rebsamen, MC; Sun, J | 1 |
3 other study(ies) available for dichlororibofuranosylbenzimidazole and calcitriol
| Article | Year |
|---|---|
1,25-Dihydroxyvitamin D3 stimulates both alkaline phosphatase gene transcription and mRNA stability in human bone cells.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitriol; Cell Line; Dichlororibofuranosylbenzimidazole; DNA Probes; Enzyme Activation; Humans; Protein Biosynthesis; RNA, Messenger; Time Factors; Transcription, Genetic | 1991 |
1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA.
Topics: 1-Methyl-3-isobutylxanthine; Antigens, CD; Calcitriol; Cell Line; Complement C5a; Cyclic AMP; Dichlororibofuranosylbenzimidazole; Dinoprostone; DNA-Directed RNA Polymerases; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Receptor, Anaphylatoxin C5a; Receptors, Complement; RNA, Messenger; Time Factors | 1996 |
1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase.
Topics: Animals; Blotting, Western; Calcitriol; Cell Adhesion; Cell Movement; Cells, Cultured; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Ergosterol; Muscle, Smooth, Vascular; Osteopontin; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; RNA Polymerase II; Sialoglycoproteins | 2002 |